COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,798 Articles (22,527 medRxiv, 8,271 bioRxiv)

Most recent first Previous |  Page 1863: Articles 18621-18630  | Next

Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
Silveira, M. A. D., De Jong, D., Galvao, E. B. d. S., Ribeiro, J. C., Silva, T. C., Berretta, A. A., Amorim, T. C., San Martin, R. L. A., Conceicao, L. F. M. R. d., Gomes, M. M. D., Teixeira, M. B., Souza, S. P. d., Santos, M. H. C. A. d., Silva, M. d. O., Lirio, M., Moreno, L., Sampaio, J. C. M., Mendonca, R., Ultchak, S. S., Amorim, F. S., Rosa, J. G., Batista, P. B. P., Guarda, S. N. F. d., Mendes, A. V. A., Passos, R. d. H.
10.1101/2021.01.08.20248932 — Posted: 2021-01-09 Discussion: Onsite
Detection of SARS-CoV-2 variants in Switzerland by genomic analysis of wastewater samples
Jahn, K., Dreifuss, D., Topolsky, I., Kull, A., Ganesanandamoorthy, P., Fernandez-Cassi, X., Bänziger, C., Stachler, E., Fuhrmann, L., Jablonski, K. P., Chen, C., Aquino, C., Stadler, T., Ort, C., Kohn, T., Julian, T. R., Beerenwinkel, N.
10.1101/2021.01.08.21249379 — Posted: 2021-01-09
An Augmented SEIR Model with Protective and Hospital Quarantine Dynamics for the Control of COVID-19 Spread
G., R.
10.1101/2021.01.08.21249467 — Posted: 2021-01-09
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys
Chen, S., Flegg, J. A., White, L. J., Aguas, R.
10.1101/2021.01.08.21249432 — Posted: 2021-01-09
COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests
Vetrugno, G., La Milia, D. I., D'Ambrosio, F., Di Pumpo, M., Pastorino, R., Boccia, S., Ricci, R., De-Giorgio, F., Cicconi, M., Foti, F., Pascucci, D., Castrini, F., Carini, E., Cambieri, A., D'Alfonso, M. E., Capalbo, G., Fantoni, M., Moscato, U., Staiti, D., De Simone, F. M., Berloco, F., Zega, M., Cattani, P., Posteraro, B., Sanguinetti, M., Laurenti, P.
10.1101/2021.01.08.21249445 — Posted: 2021-01-09
MassMark: A Highly Scalable Multiplex NGS-based Method for High-Throughput, Accurate and Sensitive Detection of SARS-CoV-2 for Mass Testing
Ngeow, K. C., Xie, C., Teo, A. K. J., Hsu, L. Y., Tan, M.-H., Choudhury, Y.
10.1101/2021.01.08.20249017 — Posted: 2021-01-09
Ivermectin as a potential treatment for mild to moderate COVID-19: A double blind randomized placebo-controlled trial
Kirti, R., Roy, R., Pattadar, C., Raj, R., Agarwal, N., Biswas, B., Manjhi, P. K., Rai, D. k., Shyama, S., Kumar, A., Sarfaraz, A.
10.1101/2021.01.05.21249310 — Posted: 2021-01-09 Discussion: Onsite
Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial
ADER, F., PEIFFER-SMADJA, N., POISSY, J., BOUSCAMBERT-DUCHAMP, M., BELHADI, D., DIALLO, A., DELMAS, C., SAILLARD, J., DECHANET, A., MERCIER, N., DUPONT, A., ALFAIATE, T., LESCURE, F.-X., RAFFI, F., GOEHRINGER, F., KIMMOUN, A., JAUREGUIBERRY, S., REIGNIER, J., NSEIR, S., DANION, F., CLERE-JEHL, R., BOUILLER, K., NAVELLOU, J.-C., TOLSMA, V., CABIE, A., DUBOST, C., COURJON, J., LEROY, S., MOOTIEN, J., GACI, R., MOURVILLIER, B., FAURE, E., POURCHER, V., GALLIEN, S., LAUNAY, O., LACOMBE, K., LANOIX, J.-P., MAKINSON, A., MARTIN-BLONDEL, G., BOUADMA, L., BOTELHO-NEVERS, e., GAGNEUX-BRUNON, A., EPAULARD, O., PIROTH, L., WALLET, F., RICHARD, J.-C., REUTER, J., STAUB, T., HITES, M., NORET, M., ANDREJAK, C., PEYTAVIN, G., LINA, B., COSTAGLIOLA, D., YAZDANPANAH, Y., BURDET, C., MENTRE, F., DisCoVeRy study group
10.1101/2021.01.08.20248149 — Posted: 2021-01-09 Discussion: Onsite
The Effect of Temperature on Covid-19 Confirmed Cases: Evidence from US Counties
NoghaniBehambari, H., Salari, M., noghani, F., tavassoli, n.
10.1101/2021.01.08.21249449 — Posted: 2021-01-09
Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy
Perez, M. M., Pimentel, V. E., Fuzo, C. A., da Silva-Neto, P. V., Toro, D. M., Souza, C. O. S., Fraga-Silva, T. F. C., Gardinassi, L. G., de Carvalho, J. C., Neto, N. T., Carmona-Garcia, I., Oliveira, C. N. S., Milanezi, C. M., Takahashi, V. N., Canassa De Leo, T., Rodrigues, L. C., Dias, C. F. S. L., Xavier, A. C., Porcel, G. S., Guarneri, I. C., Zaparoli, K., Garbato, C. T., Argolo, J. G. M., Junior, A. A. F., Feitosa, M. R., Parra, R. S., da Rocha, J. J. R., Feres, O., Vilar, F. C., Gaspar, G. G., da Silva, R. C., Constant, L. F., Ostini, F. M., Amorim, A. P., Degiovani, A. M., da Silva, D. P., Nepomuceno, D. C., Barbieri, R. C. C., Santos, I. K. F. M., Maruyama, S. R. C., Russo, E. M. S., Viana, A. L., Fernandes, A. P. M., Bonato, V. L. D., Cardoso, C. R. B., Sorgi, C. A., Dias-Baruffi, M., Faccioli, L. H.
10.1101/2021.01.07.20248970 — Posted: 2021-01-09 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).